The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain

FEBS Letters

Volumn 418, Issue 1-2, 1997, Pages 30-34

  Borden, Katherine L B ^a   Campbelldwyer, Elizabeth J ^a   Salvato, Maria S ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; HYBRID PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CELL SURVIVAL; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA VIRUS; VIRUS INFECTION;

3T3 CELLS; ANIMALS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PLAQUE ASSAY; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN FOLDING; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; RNA VIRUSES;

EID: 0030817386     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(97)01344-6     Document Type: Article

References (32)

1. Goddard A.D., Borrow J., Freemont P.S., Solomon E. Science. 254:1991;1371-1373.
2. Pandolfi P.P., et al. Oncogene. 6:1991;1285-1292.
3. Kakizuka A., et al. Cell. 66:1991;663-674.
4. Boddy M.N., et al. Oncogene. 13:1996;971-982.
5. Ascoli C.A., Maul G.G. J. Cell Biol. 112:1991;785-795.
6. Stuurman N., et al. J. Cell Sci. 101:1992;773-784.
7. Maul G.G., Ishov A.M., Everett R.D. Virology. 217:1996;67-75.
8. Korioth F., Gieffers C., Maul G.G., Frey J. J. Cell Biol. 130:1995;1-13.
9. Desbois C., Rousset R., Bantignies F., Jalinot P. Science. 273:1996;951-953.
10. Koken M.H., et al. EMBO J. 13:1994;1073-1083.
11. Dyck J.A., et al. Cell. 76:1994;333-343.
12. Weis K., et al. Cell. 76:1994;345-356.
13. Le X.F., Yang P., Chang K.S. J. Biol. Chem. 271:1996;130-135.
14. Borden K.L.B., Freemont P.S. Curr. Opin. Struct. Biol. 6:1996;395-401.
15. Saurin A.J., Borden K.L.B., Boddy M.N., Freemont P.S. Trends Biochem. Sci. 246:1996;208-213.
16. Borden K.L.B., et al. EMBO J. 14:1995;1532-1541.
17. Borden K.L.B., et al. Proc. Natl. Acad. Sci. USA. 93:1996;1601-1606.
18. Borden, K.L.B., CampbellDwyer, E.J. and Salvato, M.S., submitted.
19. Maul G.G., Everett R.D. J. Gen. Virol. 75:1994;1223-1233.
20. Kelly C., Van Driel R., Wilkinson G.W.G. J. Gen. Virol. 76:1995;2887-2893.
21. Szekely L., et al. J. Virol. 70:1996;2562-2568.
22. Ishov A.M., Maul G.G. J. Cell Biol. 134:1996;815-826.
23. Doucas V., et al. Genes Dev. 10:1996;196-207.
24. Puvion-Dutilleul F., et al. Exp. Cell Res. 218:1995;9-16.
25. Salvato, M.S. and Rai, S.K. (1996) Arenaviruses, Topley and Wilson's Medical Microbiology and Microbial Infections, Chapter 31, Arnold Publishers, London, UK.
26. Thompson C. Science. 267:1995;1456-1462.
27. King K.L., Cidlowski J.A. J. Cell. Biochem. 58:1995;175.
28. Roagia D., et al. Leukemia. 9:1995;1467-1472.
29. Terris B., et al. Cancer Res. 55:1995;1590-1597.
30. Jacobson M.D., et al. Nature. 361:1993;365.
31. Raff M.C. Nature. 356:1992;397-400.
32. Harlow, E. and Lane, D. (1988) Antibodies. A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.